The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advisory bodies and committees (358)
- Scheduling (national classification system) (155)
- Prescription medicines (34)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicine safety (22)
- Therapeutic goods regulation (19)
- Medical devices safety (13)
- Manufacturing (11)
- Safety (10)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Registered complementary medicines (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Clinical trials (2)
- Compliance and enforcement hub (2)
- Import and export (2)
- Sunscreens (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
706 result(s) found, displaying 126 to 150
-
PublicationsThis Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities.
-
PublicationsThe TGA is working with the Australian Commission on Safety and Quality in Health Care and Australian hospitals, peak bodies, and state, and territory governments to improve and increase rapid information sharing about medical device safety and effectiveness
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsCommunique from the 3rd meeting of the Women's Health Products Working Group (WHPWG), 27 March 2023
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 13 April 2023.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
PublicationsThe Access Consortium is offering joint pipeline meetings to pharmaceutical and biotechnology companies.
-
Meeting statementsMeeting statement from meeting 10 of the MDCWG.
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #40, ACCS #34, Joint ACMS-ACCS #32
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to the ACMS #40, ACCS #35 and Joint ACMS-ACCS #32 meetings held in November 2022
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 3 November 2022
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 9 February 2023.
-
PublicationsThe Action Plan will further improve Australia’s medical device regulatory system, placing patient safety first.
-
PublicationsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2022
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in November 2022
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, June 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 March 2023
-
Meeting statementsMeeting statement from meeting 9 of the MDCWG.
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), December 2022.